Axogen, Inc. — Director's Dealing 2013

Mar 5, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2013-03-01

Reporting Person: MCCARREY SHAWN F (SVP of Sales)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-03-01	Stock Option (right to buy)	$3.67	A	68000	Acquired	2020-03-01	Common Stock (68000)	Direct

Footnotes

F1: All shares pursuant to the employee stock option will be fully vested on March 1, 2017(4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on December 26, 2012 (12 months from the option grant date) and an additional 12.5% of the aggregate shares each 6 months thereafter.